FBDIX
Price
$177.24
Change
+$2.78 (+1.59%)
Updated
Nov 18 closing price
Net Assets
987.26M
FSPHX
Price
$30.12
Change
-$0.01 (-0.03%)
Updated
Nov 18 closing price
Net Assets
6.22B
Interact to see
Advertisement

FBDIX vs FSPHX

Header iconFBDIX vs FSPHX Comparison
Open Charts FBDIX vs FSPHXBanner chart's image
Franklin Biotechnology Discovery A
Price$177.24
Change+$2.78 (+1.59%)
VolumeN/A
Net Assets987.26M
Fidelity Select Health Care
Price$30.12
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets6.22B
FBDIX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
FBDIX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBDIX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. FBDIX (987M). FSPHX pays higher dividends than FBDIX: FSPHX (0.02) vs FBDIX (0.00). FBDIX was incepted earlier than FSPHX: FBDIX (28 years) vs FSPHX (44 years). FBDIX (1.03) is less costly to investors than FSPHX (0.63). FSPHX is a more actively managed with annual turnover of: 40.00 vs. FBDIX (21.87). FSPHX has a lower initial minimum investment than FBDIX: FSPHX (0) vs FBDIX (1000). FBDIX annual gain was more profitable for investors over the last year : 29.65 vs. FSPHX (0.35). FBDIX return over 5 years is better than : -2.64 vs. FSPHX (-8.45).
FBDIXFSPHXFBDIX / FSPHX
Total Expense Ratio1.020.63162%
Annual Report Gross Expense Ratio1.030.63163%
Fund Existence28 years44 years-
Gain YTD44.95210.569425%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets987M6.22B16%
Annual Yield % from dividends0.000.02-
Returns for 1 year29.650.358,473%
Returns for 3 years62.9710.51599%
Returns for 5 years-2.64-8.4531%
Returns for 10 years1.6639.394%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPMHX8.480.01
+0.12%
Invesco SteelPath MLP Alpha R5
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.44N/A
N/A
Bruce
REMVX11.11N/A
N/A
RBC Emerging Markets Value Equity I
CVTCX55.08-0.41
-0.74%
Calamos Growth & Income C